It's the GeneMedi's summary page for Target/Biomarker Introduction of ALB. The page also collects GeneMedi's different modalities and formats products for ALB in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi's target-insight database-GM ITD database, the ALB target is also connected to human indications/diseases/conditions/MOA.

Target sublocation: Secreted Protein/Potential Cytokines.

This gene encodes the most abundant protein in human blood. This protein functions in the regulation of blood plasma colloid osmotic pressure and acts as a carrier protein for a wide range of endogenous molecules including hormones, fatty acids, and metabolites, as well as exogenous drugs. Additionally, this protein exhibits an esterase-like activity with broad substrate specificity. The encoded preproprotein is proteolytically processed to generate the mature protein. A peptide derived from this protein, EPI-X4, is an endogenous inhibitor of the CXCR4 chemokine receptor. [provided by RefSeq, Jul 2016]

Target IDGM-T63068
Target NameALB
Gene ID213
Gene Official NameALB
Gene AliasHSA, PRO0883, PRO0903, PRO1341
Protein Sub-locationSecreted Protein/Potential Cytokines
CategoryTherapeutics Target, INN Index

Pre-made ALB-specific INN-index biosimilar (antibody&conjugates)-izokibep, Vobarilizumab, tifalibep, Isecarosmab, Ozoralizumab, sonelokimab

Anti-ALB therapeutic INN-index antibodies and conjugates are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody for drug discovery, target MOA research, cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Cat No.Products Name (INN Index)INN Name Previous Name Target FormatOrder
GMP-Bios-INN-880Pre-Made Izokibep Biosimilar, Bispecific, Anti-ALB;IL17A/IL17 Antibody: Anti-FDAHT/HSA/PRO0883/PRO0903/PRO1341;CTLA-8/CTLA8A therapeutic antibodyizokibepALB;IL17A/IL17trivalent bispecificINN mab
GMP-Bios-ab-625Pre-Made Vobarilizumab biosimilar, Bispecific Single Domains (VH-VH'), Anti-IL6R;ALB Antibody: Anti-CD126/HIES5/IL-1Ra/IL-6R/IL-6R-1/IL-6RA/IL6Q/IL6QTL/IL6RA/IL6RQ/gp80;FDAHT/HSA/PRO0883/PRO0903/PRO1341 therapeutic antibodyVobarilizumabIL6R;ALBBispecific Single Domains (VH-VH')INN mab
GMP-Bios-INN-1022Pre-Made Tifalibep Biosimilar, Bispecific, Anti-Alb;Fcgrt Antibody: Anti-FDAHT/HSA/PRO0883/PRO0903/PRO1341;FCRN/FcgammaRn/alpha-chain therapeutic antibodytifalibepALB;FCGRTtrivalent bispecificINN mab
GMP-Bios-ab-281Pre-Made Isecarosmab biosimilar, Bispecific Single Domains (VH-VH'), Anti-ADAMTSL5;ALB Antibody: Anti-THSD6;FDAHT/HSA/PRO0883/PRO0903/PRO1341 therapeutic antibodyIsecarosmabADAMTSL5;ALBBispecific Single Domains (VH-VH')INN mab
GMP-Bios-ab-419Pre-Made Ozoralizumab biosimilar, Bispecific Single Domains (VH-VH'-VH), Anti-TNFA/TNF;ALB Antibody: Anti-DIF/TNF-alpha/TNFSF2/TNLG1F;FDAHT/HSA/PRO0883/PRO0903/PRO1341 therapeutic antibodyOzoralizumabTNFA/TNF;ALBBispecific Single Domains (VH-VH'-VH)INN mab
GMP-Bios-INN-996Pre-Made Sonelokimab Biosimilar, Bispecific, Anti-ALB;IL17A/IL17;IL17F Antibody: Anti-FDAHT/HSA/PRO0883/PRO0903/PRO1341;CTLA-8/CTLA8/IL-17A/ILA17;CANDF6/ML-1/ML1 therapeutic antibodysonelokimabALB;IL17A/IL17;IL17FBispecificINN mab

Pre-made anti-ALB inhibitory monoclonal antibody(mab, blocking antibody inhibitor)-benchmark antibody for drug discovery and mechanism of action (MOA) research

Pre-made anti-ALB benchmark inhibitory monoclonal antibody(mab, blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-ALB mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Cat No.Antibody NameFormatClassified by tagOrder
GM-Tg-hg-T63068-AbAnti-ALB monoclonal antibodymabBiofunctional antibody, Therapeutics Target antibodymonoclonal antibody.

6th Floor, Building No.2, Kangxin Road 3377, Shanghai, China
Email: [email protected]   [email protected]
Telephone: +86-21-50478399   Fax: 86-21-50478399
Privacy Policy
Chinese Website

Apply for

Sample FOC application